Vendor, Boston, MA, part of Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks, Inc.
UEI ZRHJUJQSBRA4, CAGE 563U7
4 awards and $25,522,112 obligated between March 30, 2026 and September 9, 2026, 100% under full and open competition, against 4.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Testing Laboratories and ServicesNAICS 541380 | $20,999,984 |
| Medical LaboratoriesNAICS 621511 | $4,522,128 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 4 |
| Delivery Order | 2 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75D30125C20439Definitive Contract, March 30, 2026, Full and Open Competition, 3 offers | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | Traveler-Based Genomic Surveillance ProgramNAICS 541380, PSC R408 | $20,999,984 |
| 75D30126F00004Delivery Order, May 3, 2026, Full and Open Competition, 3 offers | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | Metagenomic Next-Generation Sequencing (Mngs)NAICS 621511, PSC Q301 | $3,199,875 |
| 75D30124F00001Delivery Order, June 9, 2026, Full and Open Competition, 5 offers | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | Eo 14398NAICS 621511, PSC Q301 | $1,322,253 |
| 75D30124D20079June 9, 2026, Full and Open Competition, 5 offers | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | Eo 14398NAICS 621511, PSC Q301 | $0 |
- Places of performance
- Massachusetts
- Product and service codes
- R408 Program Management/Support ServicesQ301 Reference Laboratory Testing
- Transactions
- 6 across 4 awards